Over the last two decades Simone Mocellin has been actively involved in the following main research fields: 1) predictive and prognostic biomarkers for setting up predictive and prognostic models leading to the clinical implementation of nomograms for better patient selection and risk stratification (with special regard to cutaneous melanoma and soft tissue sarcomas); 2) the role of sentinel node biopsy and radical lymphadenectomy in the therapeutic management of patients with solid tumors (with special regard to melanoma, gastrointestinal cancer and breast cancer); 3) the role of cytoreductive surgery and locoregional treatments in the therapeutic management of patients with solid tumors (with special regard to in transit melanoma metastases, limb-threatening soft tissue sarcomas, retroperitoneal soft tissue sarcomas, peritoneal carcinomatosis and sarcomatosis, unresectable liver metastases); 4) systematic reviews and meta-analyses (in the field of cancer risk epidemiology and molecular epidemiology, diagnosis, prognosis, therapy, network meta-analysis, dose-response meta-analysis) to support guidelines of evidence based medicine.
Director of the Soft tissue, Peritoneum and Melanoma Surgical Oncology Unit
– Surgical Oncology Department, IOV-IRCCS
– Full Professor of Surgery, Department of Surgery, Oncology and Gastroenterology, University of Padua, Italy